Delivery Order SPE2DB24D2102-SPE2DB25FJJBC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chew tablets (100 count) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chewable tablets (100-count) valued at $9,871.48. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under a firm fixed price structure with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100-count units) valued at $3,095.96. This competitively awarded, firm fixed-price contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,117.25 on July 22, 2025, for the supply of Quillichew ER 20 MG chew tablets (100-count units). This firm fixed-price, competitively awarded contract represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,752.85 and an ultimate completion date of August 7, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100-count) on April 25, 2025. This competitive, non-set-aside contract reflects a firm fixed-price delivery order with an ultimate completion date of April 28, 2025. The product will be performed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This competitively awarded, firm fixed-price contract requires performance at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role...
- The Defense Logistics Agency awarded a $4,497.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillichew ER 20 mg chew tablets (100 count) with an ultimate completion date of August 4, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $906 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one day period of performance from July 12 to July 13, 2023. The Defense Logistics Agency routinely issues delivery orders against various...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.06 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract employs firm fixed price terms and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB25FJJBCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,014.51 to AmerisourceBergen Drug Corp for 100 tablets of Quillichew ER 30 mg chew tablets. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which supports pharmaceutical supply requirements for military healthcare systems and other federal agencies globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies through competitive procurement processes. The DLA's reliance on AmerisourceBergen through multiple delivery orders reflects the vendor's established position as a key supplier within the military health supply chain for both specialty and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/21/25 |